1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of patients with multiple primary tumors
    Meeting Abstract

    Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Kemel, Y.; Tkachuk, K.; Liu, Y. L.; Carlo, M. I.; Walsh, M. F.; Latham, A.; Dubard-Gault, M. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • MSK eConsent: Digitalizing the informed consent process to improve participant engagement and understanding
    Meeting Abstract

    Buckley, M. T.; Lengfellner, J. M.; Koch, M. J.; Search, B.; Hoidra, C.; Lin, M.; Kundu, S.; Cambria, R.; O'Shea, M.; Galle, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Moukarzel, L. A.; Ptashkin, R.; Gao, T.; Patel, M.; Caltabellotta, N.; Braunstein, L. Z.; Aghajanian, C.; Hyman, D. M.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Risk of venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer
    Meeting Abstract

    Basaran, D.; Suhner, J.; Sassine, D.; Boerner, T.; Liu, Y. L.; Grisham, R. N.; Tew, W. P.; Gardner, G. J.; Zivanovic, O.; Sonoda, Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PFS by blinded independent central review (BICR) in the VELIA trial of veliparib (V) plus carboplatin/paclitaxel (CP) and as monotherapy in newly diagnosed patients (pts) with high-grade serous ovarian cancer (HGSC)
    Meeting Abstract

    Aghajanian, C.; Bookman, M. A.; Fleming, G. F.; Brady, M. F.; Swisher, E. M.; Steffensen, K. D.; Friedlander, M.; Okamoto, A.; Moore, K. N.; Sullivan, D. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of niraparib in older patients with advanced ovarian cancer (OC): Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
    Meeting Abstract

    Heitz, F.; Valabrega, G.; Pothuri, B.; Oaknin, A.; Graybill, W.; Sanchez, A. B.; McCormick, C.; Baurain, J. F.; Hoskins, P.; Denys, H.; more...
    Geburtshilfe und Frauenheilkunde (2020)

    Fulltext@MSK | Save
  • Timing of adverse events during maintenance treatment with rucaparib for recurrent ovarian cancer in the phase III ARIEL3 study
    Meeting Abstract

    Dean, A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Colombo, N.; Weberpals, J.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • MOONSTONE/GOG-3032: A phase II, open-label, single-arm study to evaluate the efficacy and safety of niraparib + dostarlimab in patients with platinum-resistant ovarian cancer
    Meeting Abstract

    Randall, L. M.; O'Malley, D. M.; Monk, B. J.; Coleman, R. L.; O'Cearbhaill, R. E.; Gaillard, S.; Adams, S.; Cappuccini, F.; Huang, M.; Chon, H. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1
    Meeting Abstract

    Banerjee, S.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Veliparib with carboplatin and paclitaxel in frontline high-grade serous ovarian cancer (HGSOC): Efficacy and safety of paclitaxel weekly and every 3 weeks in the VELIA study
    Meeting Abstract

    Okamoto, A.; Fleming, G.; Bookman, M.; Brady, M. F.; Swisher, E. M.; Steffensen, K. D.; Cloven, N. G.; Enomoto, T.; O'Malley, D. M.; Van Le, L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save